Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Depreciation & Amortization - Total (2014 - 2015)

Updated

Northwest Biotherapeutics' Depreciation & Amortization - Total was $3,000 in Q1 2015.

Analysis

Northwest Biotherapeutics (NWBO) Depreciation & Amortization - Total (2014 - 2015) Analysis & Trends

For FY2014, Depreciation & Amortization - Total at Northwest Biotherapeutics came in at $10,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 3,000.00
Dec 31, 2014 -390,000.00
API Access

Northwest Biotherapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=NWBO&period=max&api_key=YOUR_API_KEY